Open Access
Volume 9, Number 1, March 2019
Article Number 6
Number of page(s) 4
Published online 22 February 2019
  1. Thoenes W, Storkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch. B Cell Pathol Incl Mol Pathol. 1985; 48(3): 207–17 [CrossRef] [PubMed] [Google Scholar]
  2. Amin MB, Amin MD, Tamboli P, Javidan J, Stricker H, De-Peralta Venturina M, et al. Prognostic impact of histological subtyping of adult renal epithelial neoplasms. Am J Surg Pathol. 2002; 26(3): 281–91 [CrossRef] [PubMed] [Google Scholar]
  3. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004 [Google Scholar]
  4. Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, et al. Chromophobe renal cell carcinoma: histomorpho- logic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008; 32(12): 1822–934 [CrossRef] [PubMed] [Google Scholar]
  5. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol. 1995; 154(3): 964967 [CrossRef] [Google Scholar]
  6. Akhtar M, Kardar H, Linjawi T, McClintock J, Ali MA. Chromophobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases. Am J Surg Pathol. 1995; 19(11): 1245–56 [CrossRef] [PubMed] [Google Scholar]
  7. Parada DD, Peña KB. Chromophobe renal cell carcinoma with neuroendocrine differentiation. APMIS. 2008; 116(9): 859–65 [CrossRef] [Google Scholar]
  8. Nagashima Y. Chromophobe renal cell carcinoma: Clinical, pathological and molecular biological aspects. Pathol Int. 2000; 50(11): 872–8 [CrossRef] [Google Scholar]
  9. Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes In renal cell carcinoma: a population-based study. BJU Int. 2009; 103(11): 1496–500 [CrossRef] [PubMed] [Google Scholar]
  10. Kuroda N, Toi M, Hiroi M, Enzan H. Review of chromophobe renal cellcarcinoma with focus on clinical and pathobiological aspects. Histol Histopathol. 2003; 18(1): 165–71 [PubMed] [Google Scholar]
  11. Vera-Badillo FE, Conde E, Duran I. Chromophobe renal cell carcinoma:a review of an uncommon entity. Int J Urol. 2012; 19(10): 894–900 [CrossRef] [PubMed] [Google Scholar]
  12. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, et al. Sarcomatoid renal cell carcinoma; an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004; 28(4): 435–441 [CrossRef] [PubMed] [Google Scholar]
  13. De Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, et al. Sarcomatoid differentiaton in renal cell carcinoma; a study of 101 cases. Am J Sur Pathol. 2001; 25(3); 275–84 [CrossRef] [Google Scholar]
  14. Sto’rkel S, Steart PV, Drenckhalm D, Thoenes W. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol. 1989; 56(4): 237–45 [CrossRef] [Google Scholar]
  15. Wu SL, Fishman IJ, Shanon RL. Chromophobe renal cell carcinoma with extensive calcification and ossification. Ann of Diag pathol. 2002; 6(4): 244247 [Google Scholar]
  16. Onishi T, Oishi Y, Yauda S, Abe K, Hasegawa T, Maeda S. Prognostic implications of histological features in patients with chromophobe RCC. BJU Int. 2002; 90(6): 529–32 [CrossRef] [PubMed] [Google Scholar]
  17. Storkel S, Martignoni G, van den Berg E. Chromophobe renal cell carcinoma. In: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC. 2004; 30–2 [Google Scholar]
  18. Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S. Over expression of KIT in chromophobe renal cell carcinoma. Oncogene. 2003; 22(6): 847–52 [CrossRef] [Google Scholar]
  19. Petit A, Castillo M, santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in different Renal Cell Neoplasm. Am J Surg Pathol. 2004; 28(5): 676–8 [CrossRef] [PubMed] [Google Scholar]
  20. Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002; 20(9): 2376–81 [CrossRef] [PubMed] [Google Scholar]
  21. Zardavas D, Meisel A, Samaras P, Knuth A, Renner C, Pestalozzi BC, et al. Temsirolimus is highly effective as third line treatment in chromophobe renal cell cancer. Case Rep Oncol. 2011; 4(1): 16–8 [CrossRef] [PubMed] [Google Scholar]